Type 1 diabetes is a lifelong autoimmune disease requiring intensive daily management. While there's no cure yet, modern insulin therapy, technology, and comprehensive care allow children to live full, healthy lives. The key pillars are intensive insulin therapy, frequent glucose monitoring, carbohydrate counting, regular exercise, and psychosocial support.
💉 Insulin Therapy: The Foundation
Types of Insulin
| Type | Examples | Onset | Peak | Duration |
|---|---|---|---|---|
| Rapid-Acting | Lispro, Aspart, Glulisine | 10-15 min | 1-2 hr | 3-5 hr |
| Long-Acting | Glargine, Detemir | 1-2 hr | No peak | 18-24+ hr |
| Ultra-Long-Acting | Degludec, Glargine U-300 | 1-2 hr | No peak | 42+ hr |
Insulin Regimens
- Basal-Bolus (Gold Standard):
- Basal: Long-acting once/twice daily
- Bolus: Rapid-acting before meals
- Most flexible, best control
- Insulin Pump Therapy:
- Continuous subcutaneous infusion
- Most flexible option
- Requires education and motivation
Insulin Dosing Calculations
- Total Daily Dose (TDD):
- Honeymoon: 0.3-0.5 units/kg/day
- Prepubertal: 0.7-1.0 units/kg/day
- Pubertal: 1.0-1.5 units/kg/day
- Insulin-to-Carb Ratio: 500 ÷ TDD
- Correction Factor: 1800 ÷ TDD
📊 Blood Glucose Monitoring
Monitoring Strategies
Self-Monitoring (SMBG)
- Fingerstick testing
- Before meals, bedtime, when symptomatic
- Minimum 4-6 times daily
- Painful, burdensome
Continuous Glucose Monitoring (CGM)
- Real-time glucose readings
- Trend arrows show direction
- Alarms for highs/lows
- Examples: Dexcom, Freestyle Libre
- Game-changer for control and QOL
📈 Key Metrics
Hemoglobin A1C
- Reflects average glucose over 2-3 months
- Check every 3 months
- Target: <7.0% for most children
- Every 1% reduction = 40% complication risk reduction
Time in Range (TIR)
- % of time glucose 70-180 mg/dL
- From CGM data
- Goal: >70% time in range
- Better predictor than A1C alone
⚠️ Hypoglycemia: The Immediate Danger
Definition and Causes
Definition: Blood glucose <70 mg/dL
Symptoms
- Autonomic: Trembling, sweating, palpitations, hunger
- Neuroglycopenic: Confusion, dizziness, slurred speech, seizures
- Severe: Requires assistance from another person
Causes
- Too much insulin
- Missed or delayed meal
- Increased exercise without adjustment
- Alcohol (adolescents)
🚨 Rule of 15 for Hypoglycemia Treatment
🆘 Severe Hypoglycemia (Unconscious, Seizure)
- Glucagon injection: 0.5 mg (<20 kg) or 1 mg (≥20 kg) IM/subcutaneous
- Newer: Nasal glucagon (Baqsimi)—easier to administer
- Patient usually wakes within 10-15 minutes
- Give food once conscious
- Every family needs glucagon and training
🩺 Complications: The Long-Term Concerns
Microvascular Complications
Diabetic Retinopathy
- Leading cause of blindness in adults
- Rare in children, but starts in childhood with poor control
- Screening: Annual eye exams starting at age 11 or after 2-5 years of diabetes
Diabetic Nephropathy
- Leading cause of end-stage renal disease
- Screening: Annual urine albumin/creatinine ratio starting at age 11 or after 2-5 years
- Early sign: Microalbuminuria
Diabetic Neuropathy
- Peripheral neuropathy (numbness, tingling, pain)
- Autonomic neuropathy (GI, cardiovascular)
- Rare in children
- Screening: Annual foot exam, monofilament testing
❤️ Psychosocial Aspects: The Emotional Burden
🔬 Associated Autoimmune Conditions
Increased Risk for Other Autoimmune Diseases
| Condition | Prevalence in T1D | Screening |
|---|---|---|
| Autoimmune Thyroid Disease | 17-30% | Annual TSH, thyroid peroxidase antibodies |
| Celiac Disease | 5-10% (10x general population) | Tissue transglutaminase IgA + total IgA at diagnosis, then every 2-3 years |
| Addison's Disease | Rare but serious | Screen if symptoms (fatigue, hyperpigmentation, salt craving) |
🔑 High-Yield Clinical Pearls
- "Never stop insulin, even when sick or not eating." Illness raises glucose—may need more insulin, not less.
- "Hypoglycemia is the limiting factor in achieving tight control." Fear of lows leads to higher glucose targets.
- "Every 1% drop in A1C reduces complication risk by 40%." Tight control in childhood prevents adult complications.
- "CGM is a game-changer." Real-time data, trend arrows, and alerts dramatically improve control and quality of life.
- "Adolescence is the highest-risk period." Hormones, rebellion, and independence challenge diabetes management.
- "Rule of 15 for hypoglycemia." 15g fast-acting carb, wait 15 minutes, recheck.
- "Glucagon rescue for severe hypoglycemia." Every family needs it and must know how to use it.
- "Check for thyroid disease and celiac annually." T1D increases risk for other autoimmune conditions.
🌟 The Bottom Line: Hope and Progress
Type 1 diabetes is a lifelong autoimmune disease requiring intensive daily management. While there's no cure yet, modern insulin therapy, technology (CGM, pumps, closed-loop systems), and comprehensive care allow children to live full, healthy lives.
The key pillars are: early recognition and treatment of DKA, intensive insulin therapy using basal-bolus regimens or pumps, frequent glucose monitoring (preferably CGM), carbohydrate counting, regular exercise, psychosocial support, and screening for complications and comorbidities.
With proper management and emerging technologies, children with T1D today can expect near-normal life expectancy and quality of life. The goal isn't perfection—it's progress. Every A1C point lower, every day in target range, is a victory. Support the child and family through this marathon, celebrate successes, learn from challenges, and never stop hoping for better treatments and eventual prevention or cure.
Management Philosophy: We treat the whole child, not just the diabetes. This means addressing not only glucose control but also emotional well-being, social development, educational success, and family dynamics. Our goal is not just survival but thriving.